深度学习和影像组学在肝脏疾病影像中的临床应用:一项系统性范围综述
该系统性范围综述检索PubMed和Web of Science,从235篇候选文献中纳入45篇高质量研究,其中8篇涉及弥漫性肝病、37篇涉及局灶性肝病变;9篇使用深度学习、36篇使用影像组学。所有研究在患者选择和工作流程方面均为低偏倚风险,但36篇(80%)因缺乏外部验证在指标试验方面为高偏倚风险;研究显示这些方法可评估肝纤维化、肝硬化、门静脉高压及其并发症,预测恶性肿瘤预后并鉴别局灶性肝病变。
要点
- 45篇研究中36篇(80%)因缺乏外部验证在指标试验方面为高偏倚风险。
- 深度学习与影像组学可评估肝纤维化、肝硬化、门静脉高压及肝硬化相关并发症。
- 这些方法可预测肝脏恶性肿瘤预后并鉴别局灶性肝病变,可能成为未来临床决策支持工具。
核心结论
- 基于肝脏CT和MR影像的深度学习与影像组学在常见肝病的诊断、治疗评估和预后预测中具有潜在应用价值,未来可能成为支持临床决策的有用工具。
研究设计与样本
- 系统性范围综述,检索PubMed和Web of Science,由两名评价者独立筛选文献并提取数据,采用QUADAS-AI工具评估偏倚风险与适用性关注度;从235篇候选文献中纳入45篇高质量出版物,其中8篇关于弥漫性肝病、37篇关于局灶性肝病变;9篇研究使用深度学习,36篇使用影像组学。
诊断标准与关键数值
- 45篇研究在患者选择和工作流程方面均评为低偏倚风险。
- 36篇(80%)研究因缺乏外部验证在指标试验方面评为高偏倚风险。
- 所有45篇研究在适用性关注度方面均评为低关注。
临床应用与阅片要点
- 深度学习与影像组学可评估肝纤维化、肝硬化、门静脉高压及肝硬化引起的一系列并发症。
- 可预测肝脏恶性肿瘤的预后。
- 可鉴别局灶性肝病变。
局限性
- 36篇(80%)研究因缺乏外部验证在指标试验方面为高偏倚风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Artificial intelligence (AI) has begun to play a pivotal role in hepatic imaging. This systematic scoping review summarizes the latest progress of AI in evaluating hepatic diseases based on computed tomography (CT) and magnetic resonance (MR) imaging.
METHODS: We searched PubMed and Web of Science for publications, using terms related to deep learning, radiomics, imaging methods (CT or MR), and the liver. Two reviewers independently selected articles and extracted data from each eligible article. The Quality Assessment of Diagnostic Accuracy Studies-AI (QUADAS-AI) tool was used to assess the risk of bias and concerns regarding applicability.
RESULTS: The screening identified 45 high-quality publications from 235 candidates, including 8 on diffuse liver diseases and 37 on focal liver lesions. Nine studies used deep learning and 36 studies used radiomics. All 45 studies were rated as low risk of bias in patient selection and workflow, but 36 (80%) were rated as high risk of bias in the index test because they lacked external validation. In terms of concerns regarding applicability, all 45 studies were rated as low concerns. These studies demonstrated that deep learning and radiomics can evaluate liver fibrosis, cirrhosis, portal hypertension, and a series of complications caused by cirrhosis, predict the prognosis of malignant hepatic tumors, and differentiate focal hepatic lesions.
CONCLUSIONS: The latest studies have shown that deep learning and radiomics based on hepatic CT and MR imaging have potential application value in the diagnosis, treatment evaluation, and prognosis prediction of common liver diseases. The AI methods may become useful tools to support clinical decision-making in the future.
ADVANCES IN KNOWLEDGE: Deep learning and radiomics have shown their potential in the diagnosis, treatment evaluation, and prognosis prediction of a series of common diffuse liver diseases and focal liver lesions.
引用
- Wang, Zhang, Jiang, et al. Clinical application of deep learning and radiomics in hepatic disease imaging: a systematic scoping review. Br J Radiol. 2022. PMID: 35816550. doi:10.1259/bjr.20211136
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。